Clicky

Pyxis Oncology, Inc.(PYXS) News

Date Title
Aug 29 Pyxis Oncology to Participate in Two Upcoming Investor Conferences
Jul 29 Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
Jun 20 Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green
May 14 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
May 9 Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Mar 27 Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
Mar 21 Pyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challenges
Mar 21 Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
Mar 13 Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
Mar 7 Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
Mar 5 Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
Nov 28 Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
Aug 23 Pyxis Oncology Successfully Completes Acquisition of Apexigen
May 30 Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs
May 24 Pyxis Oncology to Acquire Apexigen
Mar 31 Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 30 Pyxis Stock Is Up 170% This Week. How Much Higher Can It Go?
Mar 22 Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update